
Merck & Co., Inc.
NYSE:MRK
75.97 (USD) • At close May 9, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Merck & Co., Inc. |
Symbool | MRK |
Munteenheid | USD |
Prijs | 75.97 |
Beurswaarde | 190,762,949,100 |
Dividendpercentage | 2.33% |
52-weken bereik | 75.83 - 134.63 |
Industrie | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Robert M. Davis J.D. |
Website | https://www.merck.com |
An error occurred while fetching data.
Over Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare company that operates in two main segments: Pharmaceutical and Animal Health. The Pharmaceutical segment specializes in human health products, with a focus on areas such as oncology, immunology, neuroscience, virology, cardiovascular, diabetes, and vaccines for all age groups. The Animal Health segment
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)
